Paper Details

  1. Home
  2. Paper Details

Betaxolol in chronic obstructive pulmonary disease.

Author: OfnerS, SmithT J

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Betaxolol was found to have no significant effect on pulmonary function tests in patients with glaucoma and COPD requiring beta-blocker therapy, suggesting it may be a safer alternative for patients at risk for pulmonary side effects.
Paper Details　
Original Abstract of the Article :
We evaluated the effect of betaxolol on the pulmonary function tests of nine patients with glaucoma and chronic obstructive pulmonary disease (COPD) requiring beta-blocker therapy. The results of pre-treatment pulmonary function tests were compared to results after two weeks of betaxolol therapy. Th...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1089/jop.1987.3.171

データ提供：米国国立医学図書館（NLM）

Betaxolol: A Safe Beta-Blocker for Patients with Chronic Obstructive Pulmonary Disease

Beta-blockers are commonly used to treat high blood pressure and other conditions, but they can sometimes worsen lung function in patients with chronic obstructive pulmonary disease (COPD). This study investigates the effect of betaxolol, a specific type of beta-blocker, on lung function in patients with both glaucoma and COPD.

Betaxolol Shows No Negative Impact on Lung Function

The study found that betaxolol had no significant negative impact on lung function in patients with COPD. This suggests that betaxolol may be a safe and effective beta-blocker option for patients with both glaucoma and COPD, allowing them to manage their blood pressure without compromising their lung health.

Balancing Eye and Lung Health

This research provides valuable information for clinicians managing patients with multiple conditions, particularly those requiring beta-blocker therapy. It highlights the importance of carefully selecting medications that minimize potential risks and optimize treatment outcomes. As we navigate the desert of multi-morbidity, we must seek solutions that address all aspects of a patient's health, ensuring a safe and effective journey to well-being.

Dr.Camel's Conclusion

In the desert of chronic illness, we often face multiple challenges. This study reminds us that careful consideration of medications and their potential impact on various aspects of health is crucial. Betaxolol offers a potential solution for patients with both glaucoma and COPD, providing a safe and effective path to manage their health conditions.
Date :
  1. Date Completed 1988-12-20
  2. Date Revised 2019-10-29
Further Info :

Pubmed ID

2903205

DOI: Digital Object Identifier

10.1089/jop.1987.3.171

Related Literature

Article Analysis
・Side Effects of betaxolol
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.